Study: Metformin Therapy May Reduce Risk of Colon Cancer in Diabetics

Researchers from the Shanghai Jiao Tong University in China have found that metformin treatment lowers the risk of colorectal cancer in patients with type two diabetes, according to a news release.

Advertisement
By: Staff

The researchers analyzed five studies from Jan. 1966-Mar. 2011, which consisted of 108,161 participants, to look for links between metformin and colon cancer incidence. The analysis revealed a 37 percent decrease in risk.

Related Articles about Colon Cancer:
Demographic Data Helps Determine Colon Cancer Risk
Bloodstream Infections Linked to Colorectal Cancer
Women Can Wait Longer Than Men to Start Colonoscopies, Study Finds

Beyond cost centers: Finding margin opportunity through encounter-level variation

Recommended Live Webinar on Mar 25, 2026 1:00 PM - 2:00 PM CST

Advertisement

Next Up in GI & Endoscopy

  • Which GIs get paid the most?

    General gastroenterologists earn an average base salary of $526,273 — more than $218,000 higher than their pediatric counterparts, who report…

    By: Patsy Newitt

  • MUSC launches advanced endoscopy program

    The MUSC Shawn Jenkins Children’s Hospital in Charleston, S.C., has launched the MUSC Advanced Pediatric Endoscopy Program and Pancreas Center. …

    By: Cameron Cortigiano
Advertisement

Comments are closed.